C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/34 (2006.01)
Patent
CA 2327413
ADMA is determined in a physiological sample by first removing interfering components: proteins by precipitation; and amines and citrulline, by means of a cation exchange column, followed by enzymatic hydrolysis of the ADMA to citrulline with DDAH. The citrulline is then determined spectrophotometrically.
On détermine la teneur en diméthyl-L-arginine asymétrique (ADMA) d'un échantillon physiologique en éliminant tout d'abord les composants perturbateurs ci-après: les protéines par précipitation ; et les amines et la citrulline au moyen d'une colonne d'échange de cations, puis par hydrolyse enzymatique de la diméthyl-L-arginine asymétrique en citrulline à l'aide de DDAH. On détermine ensuite la teneur en citrulline par spectrophotométrie.
Balint Robert F.
Cooke John P.
Mutz Mitchell Wayne
Cooke Pharma
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Panorama Research Inc.
Unither Pharma Inc.
LandOfFree
Assay for asymmetrical dimethyl-l-arginine (adma) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay for asymmetrical dimethyl-l-arginine (adma), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for asymmetrical dimethyl-l-arginine (adma) will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2063721